RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp receives regulatory approvals for cough counter, page-7

  1. 86 Posts.
    lightbulb Created with Sketch. 120
    It’s evident to see via those selling their stock so cheaply and even some posters here on HC RAP threads that they may be failing to get it.

    ResApp are developing incredible innovative 21st-century solutions that are going to disrupt how respiratory illnesses/diseases are tested, diagnosed, and managed right across the globe. We’re using archaic, slow, and expensive methods today because that's all we've had access to and the general population has accepted it.

    Here they just got the first-ever regulatory approvals to use a smartphone as a medical device, that billions and billions of us already own. This is huge. They also have proven they have successful AI where the output results or diagnosis is more accurate than humans. Massive!! Disruptions and change make many people uncomfortable. Change is slow and can take a billion steps before it’s finally approved and embraced. Much slower than ResApp perhaps foolishly anticipated and what our profit pockets and appetite want. But it is what it is. Buckle up and be patient or step off the innovation train and invest in something else. The future is exciting and I’m in and accumulating for however long this baby takes to realise.

    GLTA.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.